Literature DB >> 9717384

Cytochromes P450 in fungi.

H Vanden Bossche1, L Koymans.   

Abstract

The article gives an overview on the history of the discovery of P450 cytochromes and on their occurrence in nature, especially on their interactions with metabolic pathways in fungi. The significance of the P450 cytochromes in the ergosterol synthesis as well as in the inhibitory mechanisms caused by imidazole and triazole antimycotics is described in detail.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9717384     DOI： 10.1111/j.1439-0507.1998.tb00581.x

Source DB:  PubMed          Journal:  Mycoses        ISSN： 0933-7407            Impact factor:   4.377


  12 in total

1.  Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray.

Authors:  M D De Backer; T Ilyina; X J Ma; S Vandoninck; W H Luyten; H Vanden Bossche
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Synthesis, X-ray Single Crystal Structure, Molecular Docking and DFT Computations on N-[(1E)-1-(2H-1,3-Benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propylidene]-hydroxylamine: A New Potential Antifungal Agent Precursor.

Authors:  Reem I Al-Wabli; Alwah R Al-Ghamdi; Hazem A Ghabbour; Mohamed H Al-Agamy; James Clemy Monicka; Issac Hubert Joe; Mohamed I Attia
Journal:  Molecules       Date:  2017-02-28       Impact factor: 4.411

3.  Simultaneous determination of voriconazole and posaconazole concentrations in human plasma by high-performance liquid chromatography.

Authors:  Kathrin Kahle; Peter Langmann; Diana Schirmer; Ulrike Lenker; Daniela Keller; Annegret Helle; Hartwig Klinker; Werner J Heinz
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

4.  "In vitro" antifungal activity of protease inhibitors.

Authors:  S Mata-Essayag; S Magaldi; C Hartung de Capriles; L Deibis; G Verde; C Perez
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

5.  Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.

Authors:  R Petraitiene; V Petraitis; A H Groll; T Sein; S Piscitelli; M Candelario; A Field-Ridley; N Avila; J Bacher; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

6.  Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors.

Authors:  Partha Pratim Roy; Kunal Roy
Journal:  J Mol Model       Date:  2010-03-01       Impact factor: 1.810

7.  Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans.

Authors:  M Simitsopoulou; C Gil-Lamaignere; N Avramidis; A Maloukou; S Lekkas; E Havlova; L Kourounaki; D Loebenberg; E Roilides
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

8.  Current and promising pharmacotherapeutic options for candidiasis.

Authors:  Liliana Scorzoni; Beth Burgwyn Fuchs; Juliana Campos Junqueira; Eleftherios Mylonakis
Journal:  Expert Opin Pharmacother       Date:  2021-02-04       Impact factor: 3.889

9.  Efficacy of some natural compounds as antifungal agents.

Authors:  Sudha Vengurlekar; Rajesh Sharma; Piyush Trivedi
Journal:  Pharmacogn Rev       Date:  2012-07

10.  Angular Phenozaxine Ethers as Potent Multi-microbial Targets Inhibitors: Design, Synthesis, and Molecular Docking Studies.

Authors:  Mercy A Ezeokonkwo; Onyinyechi N Ogbonna; Sunday N Okafor; Evelyn U Godwin-Nwakwasi; Fidelia N Ibeanu; Uchechukwu C Okoro
Journal:  Front Chem       Date:  2017-11-28       Impact factor: 5.221
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.